Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

被引:90
作者
Isaacs, John T. [1 ,2 ]
D'Antonio, Jason M. [1 ,2 ]
Chen, Shuangling [1 ]
Antony, Lizamma [1 ]
Dalrymple, Susan P. [1 ]
Ndikuyeze, Georges H. [1 ]
Luo, Jun [2 ]
Denmeade, Samuel R. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Chem Therapeut Program, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Brady Urol Inst, Baltimore, MD 21205 USA
关键词
androgen receptor; origin of replication; DNA Licensing; Orc; Cdc6; Cdt1; Mcm; prostate cancer; bipolar androgen therapy; DNA-REPLICATION; CELL-CYCLE; MULTIPLE MECHANISMS; EPITHELIAL-CELLS; EUKARYOTIC CELLS; MAMMALIAN-CELLS; S-PHASE; ORIGIN; GROWTH; CDC6;
D O I
10.1002/pros.22504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell culture/xenograft and gene arrays of clinical material document that development of castration resistant prostate cancer (CRPC) cells involves acquisition of adaptive auto-regulation resulting in >25-fold increase in Androgen Receptor (AR) protein expression in a low androgen environment. Such adaptive AR increase paradoxically is a liability in castrated hosts, however, when supraphysiologic androgen is acutely replaced. Cell synchronization/anti-androgen response is due to AR binding to replication complexes (RC) at origin of replication sites (ORS) in early G1 associated with licensing/restricting DNA for single round of duplication during S-phase. When CRPC cells are acutely exposed to supraphysiologic androgen, adaptively increased nuclear AR is over-stabilized, preventing sufficient degradation in mitosis, inhibiting DNA re-licensing, and thus death in the subsequent cell cycle. These mechanistic results and the fact that AR/RC binding occurs in metastatic CRPCs directly from patients provides a paradigm shifting rationale for bipolar androgen therapy (BAT) in patient progressing on chronic androgen ablation. BAT involves giving sequential cycles alternating between periods of acute supraphysiologic androgen followed by acute ablation to take advantage of vulnerability produced by adaptive auto-regulation and binding of AR to RC in CRPC cells. BAT therapy is effective in xenografts and based upon positive results has entered clinical testing. Prostate 72:14911505, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1491 / 1505
页数:15
相关论文
共 45 条
[41]  
Vander Griend DJ, 2012, PLOS ONE IN PRESS
[42]   Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation [J].
Vander Griend, Donald J. ;
Litvinov, Ivan V. ;
Isaacs, John T. .
CELL CYCLE, 2007, 6 (06) :647-651
[43]   Cell-Autonomous Intracellular Androgen Receptor Signaling Drives the Growth of Human Prostate Cancer Initiating Cells [J].
Vander Griend, Donald J. ;
D'Antonio, Jason ;
Gurel, Bora ;
Antony, Lizamma ;
DeMarzo, Angelo M. ;
Isaacs, John T. .
PROSTATE, 2010, 70 (01) :90-99
[44]  
WAINSTEIN MA, 1994, CANCER RES, V54, P6049
[45]  
Zegarra-Moro OL, 2002, CANCER RES, V62, P1008